Women's Health IT and Software Innovations Undergo Rapid Expansion: Black Book Research Releases Comprehensive 2025 Industry Report

April 30, 2025 11:00 AM

Black Book Research today unveiled its most expansive study to date on the women's health information technology (IT) landscape, delivering a data-rich, 94-page report that captures the surging momentum of digital innovation across fertility, menopause, maternal health equity, virtual OB-GYN ecosystems, and predictive analytics.Based on responses from 455 provider organizations, 91 payer executives, and 72 employer stakeholders, the report...

Read more

Advanced Spine and Pain to Break Ground on Industry-Leading Outpatient Clinic and Surgery Center in West Valley

April 30, 2025 11:00 AM

Advanced Spine and Pain (ASAP) will break ground on a new, state-of-the-art clinic and ambulatory surgery center at 1690 N. 95th Ave., Phoenix, AZ-just outside of Avondale. The new center will expand access to specialized care for thousands of patients in the West Valley and reinforce ASAP's role as a regional leader in pain management and minimally invasive surgical care.The groundbreaking ceremony will take place at 7:30 a.m. on May 6, 2025,...

Read more

Allied OMS Partners with Three Leading Oral Surgery Practices in Southern California

April 30, 2025 9:30 AM

Allied OMS, a leading doctor-owned and doctor-led management services organization (MSO) specializing in oral and maxillofacial surgery, is pleased to announce that it has partnered with three prominent Southern California practices: TorriMed Oral Surgery and Dental Implants, Bixby Knolls Oral Surgery, and VistaMed Oral and Maxillofacial Surgery. These partnerships reinforce Allied OMS's commitment to delivering comprehensive, patient-centered...

Read more

Exousia Pro Will Launch a Web Series with Our New Consultant

April 30, 2025 9:30 AM

MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of cancer and other diseases, is launching a weekly web series titled "Ask Dr. Hausman."Our chief science officer, Dr. Marvin Hausman, will join Exousia Pro as a consultant; his contract is being finalized now. Dr. Hausman was instrumental in creating Exousia AI and establishing the Glioblastoma study...

Read more

Risen Pharma Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting

April 30, 2025 9:00 AM

Risen Pharma, a clinical stage biotech company focusing on developing treatments that address mechanisms of therapeutic resistance, today announced poster presentations on two therapeutic candidates: (1) RP04340, a potent and orally available PROTAC compound targeting KRAS G12C/D/V mutants in cancers, and (2) RP05129, a small-molecule inhibitor of ADAR1 for cancer immunotherapy, at the American Association for Cancer Research (AACR) Annual...

Read more

Hopscotch Primary Care Announces New Chief Medical Officer and Chief Financial Officer

April 30, 2025 9:00 AM

Hopscotch Primary Care ("Hopscotch" or the "Company"), an innovator delivering technology-enabled primary care to small towns and rural communities, is excited to announce the addition of two key executives to its leadership team. Dr. Aditi Mallick has joined as Chief Medical Officer (CMO), and Ashley White has joined as Chief Financial Officer (CFO).Dr. Mallick brings more than a decade of clinical and executive leadership experience to...

Read more

180 Life Sciences Corp. Announces Share Repurchase

April 30, 2025 8:30 AM

180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences," the "Company," "we," or "us") today announced that it has entered into a Settlement and Mutual Release Agreement (the "Agreement") with Elray Resources, Inc. ("Elray") and Luxor Capital, LLC ("Luxor"). The Agreement strengthens and simplifies the Company's capital structure through a significant repurchase of shares."We believe that repurchase and subsequent cancellation of a...

Read more

Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease Progression in Intestinal Failure Patients

April 30, 2025 8:15 AM

Jaguar to host investor webcast today at 8:30 AM Eastern to review the initial results from the proof-of-concept study of crofelemer for MVID and SBS-IF presented April 26 at the Annual ELITE PED-GI Congress; Click here to registerThere are no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management...

Read more

Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing

April 30, 2025 8:12 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-driven scent digitization, has announced it has formed a strategic partnership with ASE Chung Li ("ASECL") - a key site of Advanced Semiconductor Engineering, Inc., the world's leading provider of semiconductor assembly and test services. This new milestone expands the joint effort to power AI scent digitization in smart manufacturing. Under a legally binding...

Read more

Celebrate Salonpas Day and Japan Parade & Street Fair: Free Pain Relief at In-Person & Online Sampling Events in May

April 30, 2025 8:00 AM

Hisamitsu America, the marketers of Salonpas®, the world's No.1 Brand of Over-the-Counter (OTC) topical analgesics in the patch category4, is marking Salonpas Day with in-person and online product sampling events throughout May.1 In-person sampling will take place across multiple weekends in the NY Metro area, including: The Japan Parade & Street Fair is held on May 10th, at 72nd Street between Central Park West and Columbus Avenue in New York...

Read more

Infinx Patient Access Plus Listed in Epic's Connection Hub

April 30, 2025 8:00 AM

Infinx Healthcare, a trusted provider of AI-powered solutions for patient access and revenue cycle management, is excited to announce its listing in Epic's Connection Hub on Showroom, a platform for showcasing interoperable solutions within Epic. This integration highlights Infinx's commitment to improving patient access and revenue management efficiency for healthcare providers using Epic.Infinx delivers solutions that streamline patient...

Read more

HomeAid Expands Its National Impact With the Launch of HomeAid North Texas

April 30, 2025 8:00 AM

Key Findings from the local 2024 Point-in-Time Count showed that over 6,000 individuals are experiencing homelessness on any given night in the Dallas-Fort Worth area. This includes families, children, seniors, veterans, and more who face the daily challenge of finding safe and dignified housing.To help combat this issue, HomeAid has expanded its national impact to this area by launching its newest affiliate, HomeAid North Texas."The launch of...

Read more

Jointly Funded Research Explores Cutting-Edge RNA Sequencing in Rare Ovarian Cancer

April 30, 2025 6:30 AM

Two patient-driven ovarian cancer nonprofits - STAAR Low-Grade Serous Ovarian Cancer Foundation and Not These Ovaries - have awarded a $115,580 research grant to Dr. Kwong-Kwok Wong at The University of Texas MD Anderson Cancer Center to investigate new biomarkers that could improve treatment options for patients with low-grade serous ovarian cancer (LGSOC).The research study will utilize long-read RNA sequencing, a cutting-edge technology that...

Read more

Change in Number of Shares and Votes in Ascelia Pharma AB

April 30, 2025 6:00 AM

Ascelia Pharma (STO:ACE)During April, the registered number of shares and votes in Ascelia Pharma AB ("Ascelia Pharma") has increased due to the exercise of warrants series TO 1 issued in the rights issue of units resolved by the Board of Directors on 10 July 2024 and approved by the Extraordinary General Meeting on 14 August 2024. As of 30 April 2025, the total number of shares in Ascelia Pharma amounts to 117,112,647 shares, whereof...

Read more

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

April 30, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2025 ended March 31, 2025, after the market closes on Wednesday, May 7th, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To access the conference call, dial toll free 877-407-0989, for international calls, dial 201-389-0921, ten minutes before the conference.The call can also be...

Read more

UniDoc Provides Update on Marketing Engagement

April 29, 2025 7:25 PM

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media Inc. ("Rumble").Further to the Company's news release of April 3, 2025, the Company believes that its renewed engagement of Rumble is in compliance with Policy 7.2 of the Canadian Securities Exchange (the "CSE") as the Company believes that the renewed engagement of Rumble is consistent with its...

Read more

2025 Top-Rated Ambulatory Surgical Center Vendors Exhibiting at ASCA Annual Meeting, Announced by Black Book Research

April 29, 2025 4:30 PM

Black Book Research, the leading independent healthcare technology research firm, has announced the top-performing Ambulatory Surgical Center (ASC) vendors for 2025. These awards recognize industry leaders based on feedback gathered from comprehensive surveys of 954 ambulatory surgical centers nationwide, including ASC clinicians, administrators, and surgeons. Evaluations were conducted across 18 ASC-specific key performance indicators (KPIs),...

Read more

REMINDER: Jaguar Health Hosting April 30 Investor Webcast to Present Initial Results from Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF)

April 29, 2025 4:15 PM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics today issued a reminder that Jaguar is hosting an investor webcast on Wednesday, April 30, 2025 at 8:30 AM Eastern to review the initial results of the proof-of-concept investigator-initiated trial of a novel liquid formulation of crofelemer, Jaguar's plant-based anti-secretory prescription drug, in patients with the rare diseases...

Read more

Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results

April 29, 2025 4:05 PM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the first quarter 2025 ended March 31, 2025 after market close on Tuesday, May 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The...

Read more

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

April 29, 2025 4:00 PM

Protagenic Therapeutics, Inc. (Nasdaq:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, today announced that the Company's Board of Directors has approved a 1-for-14 reverse stock split of the Company's issued and outstanding common stock, par value $0.0001 per share (the "Common Stock") to be effective 12:01 a.m., Eastern Time, on May 5, 2025.The Company's Common Stock will continue to trade on the...

Read more